论文部分内容阅读
目的:评估诺舒(Novasure)阻抗控制子宫内膜切除系统治疗异常子宫出血的安全性和有效性。方法:对2013年1月—2014年12月在广州番禺中心医院应用诺舒(Novasure)阻抗控制子宫内膜切除系统治疗的170例异常子宫出血患者,术后1、3、6、12个月门诊随访,观察治疗效果及并发症。结果:170例均完成手术过程,诺舒治疗时间56~125 s,平均(85.3±7.7)s,术中出血均少于10 m L,子宫体长度为(5.2±0.7)cm,宫腔宽度(4.1±0.8)cm;术后6个月有效率93.5%(159/170),闭经率51.8%(88/170),术后1年有效率79.4%(135/170),闭经率45.9%(78/170)。术中术后均无明显并发症。结论:诺舒(Novasure)阻抗控制子宫内膜切除系统在治疗异常子宫出血病例中安全、有效,在合并内科疾病的病例治疗中存在优势。
Objective: To evaluate the safety and efficacy of the Novasure impedance-controlled endometrial ablation system in the treatment of abnormal uterine bleeding. Methods: A total of 170 patients with abnormal uterine bleeding treated with Novasure impedance controlled endometrial ablation system at Panyu Central Hospital of Guangzhou from January 2013 to December 2014 were enrolled in this study. One, three, six and 12 months after operation Outpatient follow-up, observation of treatment and complications. Results: All the 170 patients completed the operation. The duration of nosok was 56 ~ 125 s (average, 85.3 ± 7.7 s), the bleeding was less than 10 m L, the length of the uterus was (5.2 ± 0.7) cm, (4.1 ± 0.8) cm. The effective rate was 93.5% (159/170), the rate of amenorrhea was 51.8% (88/170) at 6 months after operation, the effective rate was 79.4% (135/170) (78/170). There was no obvious postoperative complications. CONCLUSIONS: The Novasure impedance-controlled endometrial ablation system is safe and effective in the treatment of patients with abnormal uterine bleeding and has advantages in the treatment of patients with medical conditions.